Statistics·Glossary term

Beta Spending

Beta Spending A/B testing Reference guide

Beta Spending is a concept used in statistical tests & methods.

Quick definition: Beta spending is a group-sequential design tool that allocates the experiment’s Type II error budget, β, across planned interim analyses to support a prespecified futility rule while retaining target power at the maximum information.

What is beta spending?

In a fixed-horizon test, β is the probability of failing to reject the null when a specified alternative effect is true; power is 1 − β. In a group-sequential experiment, evidence is reviewed before the maximum sample. Beta spending distributes the allowable false-negative risk over those planned looks, usually to define nonbinding futility boundaries. It is the power-side companion to alpha spending, which controls false-positive risk for efficacy decisions.

A beta-spending function says how much β has been spent by each information fraction. Early spending permits stopping a treatment that is unlikely to meet the target effect; late spending waits for more evidence. The exact boundary is derived from the joint distribution of interim test statistics, not by comparing ordinary p-values to a casual threshold.

How beta-spending designs work

Before launch, specify a primary estimand, one-sided or two-sided hypothesis, target effect, maximum information, alpha-spending rule, beta-spending rule, and interim information fractions. For example, a conversion test may target 90% power to detect a 0.3 percentage-point lift with maximum 40,000 mature users and looks at 50%, 75%, and 100% information.

At each look, the standardized effect statistic is compared with an efficacy boundary and a futility boundary. Crossing efficacy supports success under the alpha rule. Crossing futility says that, given the design’s target alternative, continuing is not justified under the stated rule. “Nonbinding” means the team may continue despite crossing futility without inflating Type I error, but doing so should be documented; it changes expected sample size and can undermine the operational purpose.

At information fraction t, a beta-spending function g(t) allocates cumulative β, with g(0)=0 and g(1)=β. Boundary software converts that allocation into critical interim values using the planned correlation between Z-statistics.

Assumptions and prerequisites

Information is not necessarily raw assigned users. It must reflect precision for the actual analysis, and each review needs mature outcome windows. If a renewal metric matures after 28 days, looking at new users after three days changes the estimand. Randomization, inclusion rules, exposure, metric calculation, and analysis method must remain stable or have a protocol-defined adjustment.

Futility depends on a chosen alternative effect. A rule designed around a 0.3-point lift can stop a test even if a smaller positive effect is plausible. That is appropriate only if 0.3 points is the smallest effect worth acting on. Define this practical threshold with product owners before launch, alongside harm thresholds and guardrail metrics.

Beta spending in A/B testing

Beta spending helps when a product team wants to stop unpromising variants without treating every dashboard view as proof of failure. It is suitable for expensive, high-traffic, or potentially harmful tests with a known maximum sample and a small number of scheduled reviews. It is not necessary for a simple fixed-horizon test, and it cannot make a delayed metric quick.

Use a separate safety path for urgent harms. A beta-spending futility boundary asks whether a beneficial target effect remains sufficiently plausible; it is not a safety monitor. Similarly, check sample ratio mismatch, tracking failures, and exposure anomalies before either efficacy or futility decisions.

Worked example: an onboarding flow

An onboarding change targets a 1.0-point activation lift. The protocol sets 90% power, β = 0.10, and maximum information of 30,000 matured users, with looks at 15,000, 22,500, and 30,000. It chooses conservative early beta spending, so the first futility boundary is crossed only when the observed effect is clearly incompatible with the target.

At 15,000 mature users the estimated lift is 0.05 points with an interval spanning modest loss to 0.15 points. The prescribed futility calculation shows little chance of reaching the efficacy boundary by maximum information under the target alternative. The team stops for futility. The conclusion is not “the experience has no effect”; it is “under the planned target and rule, further data are unlikely to support the success claim.” A 0.2-point lift may still be plausible, but if it is below the minimum useful effect, that is not a reason to continue.

Interpretation and reporting

Report information fraction, mature sample size, observed arm values, effect and interval, efficacy and futility boundary status, beta-spending function, target effect, and all deviations. Distinguish a futility decision from equivalence or non-inferiority. To establish that a treatment is not worse than an acceptable margin, design and analyze that question directly.

Risks and limitations

  • Target-effect misspecification can make futility too aggressive or too weak.
  • Outcome delay can render interim looks operationally unhelpful.
  • Complexity demands simulation, locked data, and clear governance.
  • Continuing after futility can create selective narratives.
  • Beta spending does not control false positives; alpha spending or another valid efficacy method is still required.

Common mistakes

  • Calling any non-significant interim result futility.
  • Using total enrollment rather than mature information.
  • Setting the target effect after viewing early results.
  • Interpreting a futility stop as proof of no effect.
  • Changing metrics or segmentation rules while retaining confirmatory status.

Frequently asked questions about beta spending

Is beta spending the same as alpha spending?

No. Alpha spending controls false positives for efficacy; beta spending allocates false-negative risk and guides futility.

Does a futility stop prove equivalence?

No. It says the planned success criterion is unlikely to be reached. Equivalence needs a margin and dedicated design.

Are futility boundaries binding?

They are often nonbinding statistically, but should be binding operationally unless a documented exception is justified.

Can beta spending be used with Bayesian tests?

It is a frequentist group-sequential concept. Bayesian predictive probability can define futility, but it has different assumptions and guarantees.

How are boundaries chosen?

Choose the design through simulation or validated sequential-design software, evaluating Type I error, power, expected duration, and plausible data problems.

Summary

Beta spending makes early futility decisions part of a calibrated sequential experiment rather than an ad hoc response to a disappointing interim chart. It requires a meaningful target effect, mature data, planned reviews, and transparent reporting; it does not prove that a stopped treatment is identical to control.

Sources